Oncology Nutrition Market by Cancer Type, Nutrition, Formula, Distribution Channel & Region for 2024-2031

Oncology Nutrition Market Valuation - 2024-2031

The oncology nutrition industry is expanding as cancer rates rise and the necessity of nutritional assistance for cancer patients becomes more widely recognized. Specialized nutrition products, including as supplements and enteral nutrition, are in high demand to help patients manage symptoms, preserve strength, and achieve better treatment outcomes. This is likely to enable the market size surpass USD 1.37 Billion valued in 2024 to reach a valuation of around USD 2.52 Billion by 2031.

Technological breakthroughs in nutritional formulae, an aging population, and supporting government regulations are all major drivers. The market is also being pushed by an increasing number of oncology nutrition studies and research projects aimed at developing unique products for specific cancer types and treatment phases. The rising demand for Oncology Nutrition is enabling the market grow at a CAGR of 7.82% from 2024 to 2031.

Oncology Nutrition Market: Definition/ Overview

Oncology nutrition specializes on giving dietary support to cancer patients. It seeks to improve treatment outcomes, control symptoms, and improve overall well-being by addressing specific nutritional requirements, cancer therapy side effects, and maintaining a healthy weight and strength.

Oncology nutrition is crucial in maintaining cancer patients' general health, assisting with recovery, and improving quality of life during and after treatment. It aids in symptom management, strength maintenance, and treatment outcomes by maintaining enough food intake customized to individual needs.

The future of oncology nutrition relies on tailored nutritional regimens to help with cancer therapy, rehabilitation, and quality of life. Advances in nutrition research and technology will allow for more precise nutrient management suited to individual patient needs, perhaps lowering treatment side effects and enhancing results.

Will Increasing Awareness of Nutrition's Role in Cancer Treatment Boost the Oncology Nutrition Market Growth?

The growing understanding of nutrition's involvement in cancer treatment is projected to greatly enhance the oncology nutrition market. According to the National Cancer Institute (NCI), malnutrition affects 30-80% of cancer patients, depending on the kind and stage of the disease. A study published in the Journal of Clinical Oncology discovered that malnutrition raises the risk of death in cancer patients by 2.4 times.

According to the American Cancer Society, malnutrition-related reasons kill 20-40% of cancer patients, not cancer itself. Nutritional therapies have been demonstrated to improve quality of life, shorten hospital stays, and potentially prevent 30-50% of cancer diagnoses with correct diet and lifestyle changes. The National Comprehensive Cancer Network (NCCN) recommendations emphasize that up to 80% of patients having chemotherapy and radiotherapy face nutritional issues.

Will Lack of Awareness and Education Hamper the Oncology Nutrition Market?

Lack of awareness and education can have a big impact on the cancer nutrition sector. Many patients and healthcare practitioners may not fully comprehend the importance of nutrition in cancer therapy, resulting in underutilization of specialist nutritional products. This information gap can lead to lost chances to improve patient outcomes, such as lowering treatment-related adverse effects, speeding up recovery, and improving overall quality of life.

Furthermore, limited education on the benefits of cancer nutrition can stymie the use of these products in clinical settings, limiting market growth. Addressing this issue would include collaborative efforts in patient education, healthcare professional training, and awareness campaigns to emphasize the necessity of nutritional assistance in cancer therapy. Increased awareness and education are important for harnessing the full potential of oncology nutrition market.

Category-Wise Acumens

Will Increasing Incidence of Breast Cancer Drive the Cancer Type Segment?

The increasing incidence of breast cancer is expected to drive the cancer type sector of the oncology nutrition market. Breast cancer is one of the most frequent tumors diagnosed worldwide, necessitating specialist dietary assistance. As the number of breast cancer cases increases, there will be a greater demand for nutrition products and interventions suited to this patient population.

These strategies can help manage treatment-related adverse effects, improve quality of life, and speed up total recovery.

Increasing knowledge of the importance of nutrition in breast cancer treatment fuels this need. As a result, the increase in breast cancer cases is predicted to greatly drive the growth of the oncology nutrition market sector that supports breast cancer patients.

Will Increasing Demand for Balanced Nutrition Suitable for A Broad Range of Patients Drive the Nutraceutical Segment?

The growing demand for balanced nutrition suitable for a wide spectrum of patients is expected to drive the nutraceutical industry. As consumers become more aware of the value of customized nutrition in treating health issues such as chronic diseases and cancer, they seek nutraceutical products that provide comprehensive health advantages. These products, which mix nutrition and medicinal characteristics, address a wide range of dietary demands and health goals.

The emphasis on individualized nutrition to promote general well-being, therapeutic outcomes, and disease prevention has sparked interest in nutraceuticals. This trend is being driven by increased health consciousness, advances in nutrition science, and a burgeoning market for dietary supplements. As people grow more aware and proactive about their health, the need for effective, balanced nutraceutical solutions is likely to skyrocket.

Country/Region-wise Acumens

Will High Prevalence of Cancer Drive the Market in North America?

The rising cancer prevalence is likely to fuel North America's oncology nutrition industry. With a large number of cancer cases and a well-established healthcare system, North America is a sizable market for specialist nutritional products meant to help cancer patients.

The demand for cancer nutrition is driven by the need for personalized nutritional interventions to reduce treatment side effects, improve patient outcomes, and improve quality of life. Furthermore, ongoing research developments and a greater emphasis on personalized treatment help to drive market expansion. North America is a leader in oncology nutrition due to its high cancer incidence, substantial healthcare infrastructure, and increased understanding of the benefits of nutritional assistance in cancer care.

Will Increasing Demand for Specialized Oncology Nutrition Products Drive the Market in Asia Pacific Region?

The Asia-Pacific market is likely to be driven by increase in demand for specialized oncology nutrition products. Rising cancer incidence, along with an aging population, is creating a growing demand for personalized nutritional solutions to aid cancer therapy and improve patient outcomes.

Increasing knowledge of the importance of nutrition in cancer care, combined with improved healthcare infrastructure and access to modern treatments, contributes to this demand.

Furthermore, economic expansion and rising disposable incomes in nations such as China and India support market growth. As healthcare facilities and cancer care improve, demand for specialized oncology nutrition products in Asia-Pacific is expected to increase significantly, propelling the market forward in this area.

Competitive Landscape

The oncology nutrition market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support. The organizations are focusing on innovating their product line to serve the vast population in diverse regions.

Some of the prominent players operating in the oncology nutrition market include:

Danone S.A.

Pfizer, Inc.

Braun Melsungen AG

Fresenius Kabi AG

Grifols S.A.

Baxter International, Inc.

Nestle S.A.

Abbott Laboratories

AbbVie, Inc.

Sichuan Kelun Pharmaceutical Co, Ltd.

Latest Developments

In January 2024, Danone partnered with Resilience, a digital oncology firm, to enhance nutritional care for cancer patients. The collaboration seeks to create a new nutrition and cancer module connected with Resilience's digital oncology platform.

In July 2022 Nestle launched China's first Foods for Special Medical Purpose (FSMP) for cancer patients, after a five-year approval process with Chinese regulatory officials.

Oncology Nutrition Market, By Category

• Cancer Type:
• Head and Neck Cancer
• Colorectal Cancer
• Hematology Cancer
• Prostate Cancer
• Breast Cancer
• Gastrointestinal Cancer
• Lung Cancer
• Pancreatic Cancer
• Nutrition:
• Enteral Nutrition
• Parenteral Nutrition
• Formula:
• Standard Formula
• Elemental Formula
• Specialized Formula
• Distribution Channel:
• Inpatient Nutrition
• Outpatient Nutrition
• Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa